Kahina Saker

7PUBLICATIONS
194CO-AUTHORS
Innate immunityCharacterisation of biological macromoleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 17, 2024
Combining SARS-CoV-2 interferon-gamma release assay with humoral response assessment to define immune memory profiles.

William Mouton, Guy Oriol, Christelle Compagnon

|Sep 16, 2022
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.

Qian Zhang, Andrés Pizzorno, Lisa Miorin

|Jul 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.

Paul Bastard, Sara E Vazquez, Jamin Liu

|May 31, 2022
Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?

Kahina Saker, Bruno Pozzetto, Antonin Bal

|Jan 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.

Jeremy Manry, Paul Bastard, Adrian Gervais

|Aug 25, 2021
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients.

David Goncalves, Mehdi Mezidi, Paul Bastard

Pageof 2

Frequent Collaborators

5 joint publications

Sophie Trouillet-Assant

3 joint publications

Evangelos Andreakos

3 joint publications

Jean-Laurent Casanova

3 joint publications

Paul Bastard